Multiple Sclerosis Rehabilitation
CIREN provides rehabilitation for patients with multiple sclerosis (MS) and other neurodegenerative conditions. The program addresses the variable and progressive nature of MS through intensive therapy designed to manage symptoms, maintain function, and support quality of life within the Neurological Restoration Program framework.
What Is MS and Neurodegenerative Conditions Rehabilitation
Multiple sclerosis is a chronic autoimmune disease in which the immune system attacks the protective sheath (myelin) covering nerve fibers, causing communication problems between the brain and the rest of the body. Symptoms vary widely and can include fatigue, difficulty walking, numbness or tingling, muscle weakness, vision problems, and cognitive changes. MS is progressive but its course is unpredictable and varies significantly between individuals.
Rehabilitation at CIREN
CIREN's MS rehabilitation program combines intensive physiotherapy, occupational therapy, cognitive rehabilitation, and psychological support. The multidisciplinary team assesses each patient's specific symptoms and disease course to develop a personalized treatment plan. Therapy focuses on managing fatigue, maintaining mobility, addressing cognitive changes, and supporting emotional health.
What the Program Includes
Eligibility Evaluation
Eligibility is determined through medical record review and pre-evaluation. CIREN's medical team assesses the type and stage of MS, current treatment regimen, and functional status. Patients must be medically stable for intensive rehabilitation.
Multiple Sclerosis in the United States
Source: National MS Society estimates
- Nearly one million Americans are living with multiple sclerosis
- MS is typically diagnosed between ages 20 and 50
- Women are two to three times more likely to develop MS than men
- MS is more common in regions farther from the equator
The CIREN Process
From initial medical record review to follow-up after program completion, SMC Salud coordinates every step of the CIREN journey for international patients.
Medical Record Review
Patients submit their medical records, imaging studies, and current functional assessments for review by CIREN's medical team. SMC Salud assists with gathering and organizing these documents.
Pre-Evaluation
CIREN's specialists review the submitted records to determine eligibility and develop a preliminary treatment plan. This evaluation helps ensure the program is appropriate for the patient's condition.
Treatment Planning
If accepted, a personalized treatment plan is developed based on the pre-evaluation. The plan outlines the program duration, therapy components, and recovery objectives.
Travel Coordination
SMC Salud coordinates travel logistics including visa support, accommodation arrangements, and ground transportation in Havana. Patients receive a detailed travel itinerary.
Rehabilitation Program
The patient attends CIREN's intensive Neurological Restoration Program in Havana. The program includes daily therapy sessions of up to 7 hours, delivered in 4-week cycles with defined recovery objectives.
Follow-Up
After completing the program, patients receive a discharge summary and recommendations for continued rehabilitation at home. SMC Salud remains available for follow-up coordination and support.
Ready to Explore CIREN?
Request a medical evaluation to find out if CIREN's program is right for you or your loved one.
Multiple Sclerosis Rehabilitation — Questions and Answers
Can CIREN cure multiple sclerosis?
No. There is currently no cure for multiple sclerosis. CIREN's rehabilitation program is designed to help manage symptoms, maintain function, and improve quality of life through intensive therapy. The program does not claim to stop or reverse the disease process.
Is CIREN's MS rehabilitation suitable for all MS types?
CIREN's medical team evaluates each patient individually during the pre-evaluation process. The type of MS (relapsing-remitting, secondary progressive, primary progressive), current disease activity, and functional status are all considered in determining eligibility and developing a treatment plan.
Can MS patients continue their disease-modifying therapy at CIREN?
CIREN's medical team reviews each patient's current treatment regimen as part of the pre-evaluation. Disease-modifying therapies are coordinated with the patient's treating neurologist. Patients should not discontinue medications without medical supervision.
Medical Disclaimer: Information about CIREN's programs is provided for educational purposes only. SMC Salud facilitates coordination and travel logistics; all medical decisions are made by CIREN's medical team following individual evaluation. Rehabilitation outcomes vary by individual and cannot be guaranteed.